UCLH and UCL researchers have set out how artificial intelligence (AI) can and should be harnessed to transform hearing healthcare and research.
UCLH consultant Professor Sir Ali Zumla been awarded the prestigious EU-EDCTP Pascoal Mocumbi Prize for outstanding scientific research, health services capacity building, training and advocacy achievements in Africa.
An anti-viral gene that increases the risk of both Alzheimer’s disease and severe Covid-19 has been identified by a UCL-led research team.
UCL scientists have found that people with the Alzheimer’s risk gene, APOE4, perform better in visual working memory tests than people without the gene.
People can safely receive the Covid-19 and influenza vaccine at the same time, according to a new study. The ‘Combining Influenza and Covid-19 Vaccination (ComFluCOV) study’ published as a preprint, found that immune responses to both the influenza and Covid-19 vaccine were preserved when given
A pilot service at UCLH set up by clinicians and researchers that enables ear, nose and throat (ENT) surgeons to assess hearing and ear problems remotely and shorten treatment pathways has won the ENT UK’s Best Young Consultant Led Research, Audit or Training prize.
The BRC has published a magazine for patients and the public on the latest research at UCLH
Being a young adult aged 18 to 24 is a more important risk factor for weight gain than sex, ethnicity, geographic region, or socioeconomic area characteristics, according to a new study.
An antibody treatment trialled at UCLH cuts the risk of developing symptomatic COVID-19 by 77%.
Researchers are applying AI technology to ‘unlock’ data held in patients’ health records so that it can be used to improve care, planning and research.
UCLH is the highest recruiter among UCLPartners (UCLP) organisations in 2021 to clinical trials run in conjunction with the healthcare company IQVIA.
In a collaboration between UCLH and Imperial College, researchers have developed a new test which could help doctors more easily distinguish what kind of infection a patient may have and prescribe treatments more quickly.
Patient and public involvement (PPI) training brings about immediate and marked increases in the confidence and skills of researchers to involve the public in their work, according to a study at the BRC.
A national study involving UCLH has deepened understanding of the symptoms, signs and outcomes of patients with the novel condition vaccine-induced immune thrombocytopenia and thrombosis (VITT), associated with the Oxford/AstraZeneca vaccine.
UCLH and Cambridge University in collaboration with NHS Blood and Transplant have won government funding to apply artificial intelligence (AI) to improve blood transfusions.